New Small Molecule Drugs for Thrombocytopenia: Chemical, Pharmacological, and Therapeutic Use Considerations

This review provides details about three small molecules that were recently approved by the FDA for the treatment of thrombocytopenia. The new treatments include lusutrombopag, avatrombopag, and fostamatinib. The first two drugs are orally active thrombopoietin receptor (TPO-R) agonists which are FD...

Descripción completa

Detalles Bibliográficos
Autores principales: Clemons Bankston, Page, Al-Horani, Rami A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628068/
https://www.ncbi.nlm.nih.gov/pubmed/31226783
http://dx.doi.org/10.3390/ijms20123013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628068/
https://www.ncbi.nlm.nih.gov/pubmed/31226783
http://dx.doi.org/10.3390/ijms20123013

Ejemplares similares